Oliver Engert, the Chief Administrative Officer of $ENOV, bought 1,000 shares of the company on 06-01-2026 for an estimated $22,220. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 2.1%. Following this trade, they now own 49,640 shares of this class of $ENOV stock.
$ENOV Insider Trading Activity
$ENOV insiders have traded $ENOV stock on the open market 13 times in the past 6 months. Of those trades, 9 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $ENOV stock by insiders over the last 6 months:
- OLIVER ENGERT (Chief Administrative Officer) has made 9 purchases buying 7,000 shares for an estimated $168,135 and 0 sales.
- DANIEL A PRYOR has made 0 purchases and 4 sales selling 1,665 shares for an estimated $45,297.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$ENOV Hedge Fund Activity
We have seen 141 institutional investors add shares of $ENOV stock to their portfolio, and 166 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DORSEY ASSET MANAGEMENT, LLC removed 2,279,200 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $51,851,800
- BLACKROCK, INC. added 1,029,845 shares (+11.6%) to their portfolio in Q1 2026, for an estimated $23,428,973
- WALLEYE CAPITAL LLC removed 1,015,356 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $23,099,349
- GOLDMAN SACHS GROUP INC added 720,006 shares (+84.9%) to their portfolio in Q1 2026, for an estimated $16,380,136
- FMR LLC removed 567,682 shares (-29.4%) from their portfolio in Q1 2026, for an estimated $12,914,765
- CITADEL ADVISORS LLC added 546,383 shares (+232.1%) to their portfolio in Q1 2026, for an estimated $12,430,213
- EXODUSPOINT CAPITAL MANAGEMENT, LP removed 508,971 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $11,579,090
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$ENOV Revenue
$ENOV had revenues of $589.2M in Q1 2026. This is an increase of 5.43% from the same period in the prior year.
You can track ENOV financials on Quiver Quantitative's ENOV stock page.
You can access data on ENOV stock through the Quiver Quantitative API.
$ENOV Analyst Ratings
Wall Street analysts have issued reports on $ENOV in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- William Blair issued a "Outperform" rating on 04/17/2026
- Needham issued a "Buy" rating on 02/26/2026
- BTIG issued a "Buy" rating on 01/06/2026
- Freedom Capital Markets issued a "Buy" rating on 12/17/2025
To track analyst ratings and price targets for $ENOV, check out Quiver Quantitative's $ENOV forecast page.
$ENOV Price Targets
Multiple analysts have issued price targets for $ENOV recently. We have seen 6 analysts offer price targets for $ENOV in the last 6 months, with a median target of $42.5.
Here are some recent targets:
- Ryan Zimmerman from BTIG set a target price of $39.0 on 05/22/2026
- Vijay Kumar from Evercore ISI Group set a target price of $36.0 on 05/08/2026
- Larry Biegelsen from Wells Fargo set a target price of $40.0 on 05/08/2026
- Mike Matson from Needham set a target price of $52.0 on 02/26/2026
- Keith Hinton from Freedom Capital Markets set a target price of $45.0 on 12/17/2025
- Caitlin Cronin from Canaccord Genuity set a target price of $50.0 on 12/17/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
